send link to app

ASHP Patient Drug Info


4.8 ( 1568 ratings )
Références Médecine Éducation
Développeur Skyscape Medpresso Inc
Libre

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.

ASHP Patient Drug Information 2024 is an easy-to-use app that provides an up-to-date consumer drug guide with cost analysis and drug effectiveness ratings to help you discuss medications, ask the right questions, and make the best decisions with your medical provider.

Patients need up-to-date information on proper drug usage. When Patients fully understand whats expected of them, they are more likely to get the desired results from their drug therapy. Positive outcomes are achieved because patients understand the benefits and potential dangers of their medications. FamilyRx: ASHP Patient Drug Information 2024 is updated frequently and includes home infusion and cancer chemotherapy monographs.
Includes Best Buy Drugs™ from Consumer Reports Health – Compare a drug to similar drugs based on its track record for effectiveness, safety, and cost
ASHP Patient Medication Information Database includes:
* 1,550 monographs covering most prescription and over-the-counter medications and vaccines available in the US
* Includes “How To” monographs for administering different types of medications such as eye drops, inhalers, and suppositories
* Includes new and updated black box warnings.
* Identifies medications that have the potential for adverse events when used by patients 65 years of age and older as recommended by a panel of nationally recognized experts (Beers Criteria). These criteria identify medications that should generally be avoided or that should be used with caution in older adults
As a care provider:
* Build trust with patients by providing useful, understandable information on their medications.
* Improve communication and patient compliance.
* Empower patients to be more active and involved in their treatment.
* Monographs are available in both English and Spanish and are written at a 6th- to 8th-grade reading level

Why ASHP Patient Medication Information?
- Top Ten Award Winner in the Department of Health and Human Services National Consumer Education Materials Contest Published by ASHP, long recognized as an authority on educating patients about drug use and safety.

- AHFS Patient Medication Information (PMI) is a Patient Drug Guide - from the American Society of Health-System Pharmacists, ASHP PMI is the first private sector publication developed for educating consumers and patients about their drug. Published by ASHP, long recognized as an authority on educating patients about drug use and safety.

- ASHP PMI Database conforms to the U.S. Department of Health and Human Services Keystone Guidelines for the provision of ""useful"" prescription medicine information to consumers and the FDAs Guidance for Useful Written Consumer Medication Information

SUBSCRIPTION :

Please choose an auto renewable subscription plan to receive content access and continuous updates. Your subscription automatically renews as per your plan, so you always have the latest content.

One months auto-renewing payments - $0.99
Three months auto-renewing payments - $1.99
Yearly auto-renewing payments- $4.99

Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.

If you have any questions or comments, email us any time: [email protected] or call 508-299-3000

Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx

Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx

Publisher/Editor(s): American Society of Health-System Pharmacists, Inc.